| 000 | 01058 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512023902.0 | ||
| 264 | 0 | _c19880629 | |
| 008 | 198806s 0 0 eng d | ||
| 022 | _a0142-2782 | ||
| 024 | 7 |
_a10.1002/bod.2510090204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPierce, D M | |
| 245 | 0 | 0 |
_aPharmacokinetics of indoramin and its 6-hydroxylated metabolite after repeated oral dosing. _h[electronic resource] |
| 260 |
_bBiopharmaceutics & drug disposition _c |
||
| 300 |
_a147-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacokinetics |
| 650 | 0 | 4 |
_aIndoramin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aWarrington, S J | |
| 700 | 1 | _aFranklin, R A | |
| 773 | 0 |
_tBiopharmaceutics & drug disposition _gvol. 9 _gno. 2 _gp. 147-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bod.2510090204 _zAvailable from publisher's website |
| 999 |
_c2903061 _d2903061 |
||